Cleared Abbreviated

K231804 - PRIME-XV FreezIS DMSO-Free MD (FDA 510(k) Clearance)

Nov 2023
Decision
142d
Days
Class 2
Risk

K231804 is an FDA 510(k) clearance for the PRIME-XV FreezIS DMSO-Free MD. This device is classified as a Media, Culture, Ex Vivo, Tissue And Cell (Class II - Special Controls, product code NDS).

Submitted by Fujifilm Irvine Scientific (Santa Ana, US). The FDA issued a Cleared decision on November 9, 2023, 142 days after receiving the submission on June 20, 2023.

This device falls under the Gastroenterology & Urology FDA review panel. Regulated under 21 CFR 876.5885.

Submission Details

510(k) Number K231804 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 20, 2023
Decision Date November 09, 2023
Days to Decision 142 days
Submission Type Abbreviated
Review Panel Gastroenterology & Urology (GU)
Summary Summary PDF

Device Classification

Product Code NDS - Media, Culture, Ex Vivo, Tissue And Cell
Device Class Class II - Special Controls
CFR Regulation 21 CFR 876.5885